Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). SARS-CoV-2 has been spreading worldwide since December 2019, resulting in the ongoing COVID-19 pandemic with 237 million infections and 4.8 million deaths by 11 October 2021. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Dongyan, Zhou, Runhong, Chen, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Adoptive Cellular Immunotherapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755319/
https://www.ncbi.nlm.nih.gov/pubmed/35915816
http://dx.doi.org/10.1093/immadv/ltab027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755319/
https://www.ncbi.nlm.nih.gov/pubmed/35915816
http://dx.doi.org/10.1093/immadv/ltab027

Ejemplares similares